Quantum-Si incorporated (QSIAW)
NASDAQ: QSIAW · Real-Time Price · USD · Warrants
0.1000
-0.0100 (-9.09%)
Apr 2, 2026, 4:00 PM EDT - Market closed

Company Description

Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS).

The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer’s protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS.

It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results.

The company was founded in 2013 and is headquartered in Branford, Connecticut.

Quantum-Si incorporated
Quantum-Si incorporated logo
CountryUnited States
Founded2013
IndustryBiotechnology
SectorHealthcare
Employees145
CEOJeffrey Hawkins

Contact Details

Address:
29 Business Park Drive
Branford, Connecticut 06405
United States
Phone866 688 7374
Websitequantum-si.com

Stock Details

Ticker SymbolQSIAW
ExchangeNASDAQ
Stock TypeWarrants
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001816431
CUSIP Number74765K113
ISIN NumberUS74765K1135

Key Executives

NamePosition
Jeffrey Alan HawkinsPresident, Chief Executive Officer and Director
Dr. Jonathan M. Rothberg Ph.D.Founder and Executive Director
Jeffry R. Keyes CPAChief Financial Officer and Treasurer
Todd RearickChief Technology Officer
Dr. Christian Lapointe J.D., Ph.D.General Counsel and Corporate Secretary
Lindsay ThompsonChief Human Resources Officer
Dr. John S. Vieceli Ph.D.Chief Product Officer